Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-transplantation Lymphoproliferative Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05258136
What this trial is testing

Low-dose CD20 Monoclonal Antibody Injection in Preemptive Treatment of PTLD in Patients With EBV-HLH/CAEBV

Who this might be right for
PTLDCAEBVHLH
Beijing Friendship Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT03104491
What this trial is testing

Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

Who this might be right for
Acute Lymphocytic Leukemia
Leland Metheny 44
Testing effectiveness (Phase 2)Ended earlyNCT00240162
What this trial is testing

PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 21
Post-approval studies (Phase 4)Looking for participantsNCT04989491
What this trial is testing

Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft

Who this might be right for
Epstein-Barr Virus Infections
University Hospital, Strasbourg, France 120
Testing effectiveness (Phase 2)Study completedNCT00530218
What this trial is testing

Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiableLeukemiaLymphoma+3 more
City of Hope Medical Center 61
Early research (Phase 1)Study completedNCT00729118
What this trial is testing

Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
Ohio State University Comprehensive Cancer Center 19
Large-scale testing (Phase 3)Active Not RecruitingNCT06475820
What this trial is testing

Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaBiphenotypic Acute Leukemia+2 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 150
Early research (Phase 1)Study completedNCT01087294
What this trial is testing

Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation

Who this might be right for
Leukemia, B-cellLymphoma, HodgkinsLymphoma, Non-hodgkins+1 more
National Cancer Institute (NCI) 85
Testing effectiveness (Phase 2)Looking for participantsNCT03970096
What this trial is testing

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+2 more
Fred Hutchinson Cancer Center 120
Large-scale testing (Phase 3)Looking for participantsNCT03562169
What this trial is testing

The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)

Who this might be right for
Multiple Myeloma
University of Leeds 406
Early research (Phase 1)Looking for participantsNCT06672705
What this trial is testing

Epcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders

Who this might be right for
Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative DisorderEBV-Related Post-Transplant Lymphoproliferative DisorderRecurrent Monomorphic Post-Transplant Lymphoproliferative Disorder+3 more
Timothy Voorhees
Not applicableStudy completedNCT03323541
What this trial is testing

Use of Zarzio® in Post-autologous Stem Cell Transplantation Procedure

Who this might be right for
Multiple MyelomaNon-hodgkin LymphomaHodgkin Lymphoma
University Hospital, Brest 62
Testing effectiveness (Phase 2)Looking for participantsNCT05805605
What this trial is testing

Allo HSCT Using RIC and PTCy for Hematological Diseases

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaBiphenotypic Acute Leukemia+15 more
Masonic Cancer Center, University of Minnesota 56
Testing effectiveness (Phase 2)UnknownNCT00048464
What this trial is testing

T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant

Who this might be right for
Multiple Myeloma
Xcyte Therapies 35
Testing effectiveness (Phase 2)Ended earlyNCT01458548
What this trial is testing

Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD)

Who this might be right for
Post-transplantation Lymphoproliferative Disorder
Charite University, Berlin, Germany 70
Testing effectiveness (Phase 2)Study completedNCT02168101
What this trial is testing

Determining the Feasibility of MLN9708 as Maintenance After Allogeneic Stem Cell Transplant for Multiple Myeloma

Who this might be right for
Multiple Myeloma
SCRI Development Innovations, LLC 9
Testing effectiveness (Phase 2)Looking for participantsNCT06723457
What this trial is testing

Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Polymorphic Post-Transplant Lymphoproliferative DisorderRefractory B-Cell Non-Hodgkin Lymphoma
Reem Karmali 34
Testing effectiveness (Phase 2)Looking for participantsNCT07368634
What this trial is testing

Exploratory Study of EBV-TCR-T Cell Injection for EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Epstein-Barr Virus InfectionPost-Transplant Lymphoproliferative Disorder
Daihong Liu 18
Early research (Phase 1)Active Not RecruitingNCT06523699
What this trial is testing

Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Reconstitution in Multiple Myeloma Patients After Autologous Hematopoietic Cell Transplant

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 30
Not applicableLooking for participantsNCT07488728
What this trial is testing

Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic Lymphohistiocytosis

Who this might be right for
EBV-associated T/NK-cell Lymphoproliferative DiseasesRefractory/Relapsed EBV-related Hemophagocytic LymphohistiocytosisLetermovir
Beijing Children's Hospital 80
Next Page
26